Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
A pilot study by ProgenaBiome evaluating the role of gut flora in Epidermolysis Bullosa has been withdrawn. The study covered Epidermolysis …
-
CLINICAL_TRIALS withdrawal · 2021-06-18Clinical Trial Update: The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial [Phase 2, Phase 3]
A Phase II/III trial evaluating 3% cannabidiol (CBD) cream for Epidermolysis Bullosa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-10-28Clinical Trial Update: Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa [Phase 4]
A Phase 4 clinical trial evaluating tetracycline for Epidermolysis Bullosa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-04-11Clinical Trial Update: Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes [NA]
The clinical trial evaluating grafting of Epidermolysis Bullosa wounds with cultured revertant autologous keratinocytes has been withdrawn.